Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients.

Vogelberg C, Szefler SJ, Vrijlandt EJLE, Boner AL, Engel M, El Azzi G, Vulcu SD, Moroni-Zentgraf PM, Eickmeier O, Hamelmann EH.

Eur Respir J. 2019 Jun 13;53(6). pii: 1801824. doi: 10.1183/13993003.01824-2018. Print 2019 Jun.

2.

Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016.

Wetzstein N, Hügel C, Wichelhaus TA, Hogardt M, Eickmeier O, Küpper-Tetzel CP, Kann G, Just-Nübling G, Stephan C, Wolf T.

Infection. 2019 Oct;47(5):817-825. doi: 10.1007/s15010-019-01317-2. Epub 2019 May 15.

PMID:
31093923
3.

A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma.

Fussbroich D, Zimmermann K, Göpel A, Eickmeier O, Trischler J, Zielen S, Schubert R, Beermann C.

Lipids Health Dis. 2019 Jan 18;18(1):16. doi: 10.1186/s12944-018-0947-6.

4.

[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa].

Schwarz C, Schulte-Hubbert B, Bend J, Abele-Horn M, Baumann I, Bremer W, Brunsmann F, Dieninghoff D, Eickmeier O, Ellemunter H, Fischer R, Grosse-Onnebrink J, Hammermann J, Hebestreit H, Hogardt M, Hügel C, Hug M, Illing S, Jung A, Kahl B, Koitschev A, Mahlberg R, Mainz JG, Mattner F, Mehl A, Möller A, Muche-Borowski C, Nüßlein T, Puderbach M, Renner S, Rietschel E, Ringshausen FC, Schmidt S, Sedlacek L, Sitter H, Smaczny C, Tümmler B, Vonberg R, Wielpütz MO, Wilkens H, Wollschläger B, Zerlik J, Düesberg U, van Koningsbruggen-Rietschel S.

Pneumologie. 2018 May;72(5):347-392. doi: 10.1055/s-0044-100191. Epub 2018 May 14. German.

PMID:
29758578
5.

Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia.

Duecker R, Baer P, Eickmeier O, Strecker M, Kurz J, Schaible A, Henrich D, Zielen S, Schubert R.

Redox Biol. 2018 Apr;14:645-655. doi: 10.1016/j.redox.2017.11.006. Epub 2017 Nov 10.

6.

Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.

Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, Sole A, Gartner S, Milla CE, Barry PJ.

Mycopathologia. 2018 Feb;183(1):21-32. doi: 10.1007/s11046-017-0182-0. Epub 2017 Jul 31. Review.

PMID:
28762125
7.

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.

Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, Schubert R.

PLoS One. 2017 Feb 3;12(2):e0171249. doi: 10.1371/journal.pone.0171249. eCollection 2017.

8.

Airway inflammation in mild cystic fibrosis.

Eckrich J, Zissler UM, Serve F, Leutz P, Smaczny C, Schmitt-Grohé S, Fussbroich D, Schubert R, Zielen S, Eickmeier O.

J Cyst Fibros. 2017 Jan;16(1):107-115. doi: 10.1016/j.jcf.2016.05.016. Epub 2016 Jun 11.

9.

Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Pietzner J, Merscher BM, Baer PC, Duecker RP, Eickmeier O, Fußbroich D, Bader P, Del Turco D, Henschler R, Zielen S, Schubert R.

Bone Marrow Transplant. 2016 Apr;51(4):619. doi: 10.1038/bmt.2016.22. No abstract available.

PMID:
27050750
10.

Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Pietzner J, Merscher BM, Baer PC, Duecker RP, Eickmeier O, Fußbroich D, Bader P, Del Turco D, Henschler R, Zielen S, Schubert R.

Bone Marrow Transplant. 2016 Apr;51(4):560-7. doi: 10.1038/bmt.2015.334. Epub 2016 Jan 11. Erratum in: Bone Marrow Transplant. 2016 Apr;51(4):619.

PMID:
26752140
11.

CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease.

Carevic M, Singh A, Rieber N, Eickmeier O, Griese M, Hector A, Hartl D.

Eur Respir J. 2015 Aug;46(2):395-404. doi: 10.1183/09031936.00173514. Epub 2015 Apr 30.

12.

Airway inflammation in children and adolescents with bronchiolitis obliterans.

Rosewich M, Zissler UM, Kheiri T, Voss S, Eickmeier O, Schulze J, Herrmann E, Dücker RP, Schubert R, Zielen S.

Cytokine. 2015 May;73(1):156-62. doi: 10.1016/j.cyto.2014.10.026. Epub 2015 Mar 6.

PMID:
25748838
13.

Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia.

Eickmeier O, Kim SY, Herrmann E, Döring C, Duecker R, Voss S, Wehner S, Hölscher C, Pietzner J, Zielen S, Schubert R.

BMC Pulm Med. 2014 May 29;14:93. doi: 10.1186/1471-2466-14-93.

14.

Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis.

Eickmeier O, Boom Lv, Schreiner F, Lentze MJ, NGampolo D, Schubert R, Zielen S, Schmitt-Grohé S.

Mediators Inflamm. 2013;2013:913135. doi: 10.1155/2013/913135. Epub 2013 Aug 26.

15.

Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.

Friedrich-Rust M, Schlueter N, Smaczny C, Eickmeier O, Rosewich M, Feifel K, Herrmann E, Poynard T, Gleiber W, Lais C, Zielen S, Wagner TO, Zeuzem S, Bojunga J.

J Cyst Fibros. 2013 Sep;12(5):431-9. doi: 10.1016/j.jcf.2012.12.013. Epub 2013 Jan 27.

16.

Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease.

Eickmeier O, Rieber N, Eckrich J, Hector A, Graeppler-Mainka U, Hartl D.

Curr Pharm Des. 2013;19(20):3669-78. Review.

PMID:
23278535
17.

Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils.

Hector A, Kormann M, Kammermeier J, Burdi S, Marcos V, Rieber N, Mays L, Illig T, Klopp N, Falkenstein F, Kappler M, Riethmueller J, Graepler-Mainka U, Stern M, Eickmeier O, Serve F, Zielen S, Döring G, Griese M, Hartl D.

Am J Respir Cell Mol Biol. 2013 Jan;48(1):71-7. doi: 10.1165/rcmb.2012-0061OC. Epub 2012 Oct 4.

PMID:
23043087
18.

Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.

Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD.

Mucosal Immunol. 2013 Mar;6(2):256-66. doi: 10.1038/mi.2012.66. Epub 2012 Jul 11.

19.

Vocal cord dysfunction in adolescents.

Schulze J, Weber S, Rosewich M, Eickmeier O, Rose MA, Zielen S.

Pediatr Pulmonol. 2012 Jun;47(6):612-9. doi: 10.1002/ppul.21622. Epub 2012 Mar 13.

PMID:
22415978
20.

Early impact of smoking on lung function, health, and well-being in adolescents.

Rosewich M, Schulze J, Eickmeier O, Adler S, Rose MA, Schubert R, Zielen S.

Pediatr Pulmonol. 2012 Jul;47(7):692-9. doi: 10.1002/ppul.21602. Epub 2011 Dec 13.

PMID:
22170852
21.

CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease.

Kormann MS, Hector A, Marcos V, Mays LE, Kappler M, Illig T, Klopp N, Zeilinger S, Carevic M, Rieber N, Eickmeier O, Zielen S, Gaggar A, Moepps B, Griese M, Hartl D.

Eur Respir J. 2012 Jun;39(6):1385-90. doi: 10.1183/09031936.00130011. Epub 2011 Nov 16.

22.

The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.

Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AÖ, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D.

PLoS One. 2011;6(9):e24399. doi: 10.1371/journal.pone.0024399. Epub 2011 Sep 20.

23.

[Pro-resolving lipid mediators in inflammatory lung diseases].

Eickmeier O, Hilberath JN, Zielen S, Haworth O.

Pneumologie. 2011 Mar;65(3):149-58. doi: 10.1055/s-0030-1255913. Epub 2010 Nov 29. Review. German.

24.

Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

Rosewich M, Schulze J, Eickmeier O, Telles T, Rose MA, Schubert R, Zielen S.

Clin Exp Immunol. 2010 Jun;160(3):403-10. doi: 10.1111/j.1365-2249.2010.04106.x. Epub 2010 Mar 16.

25.

Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.

Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, Buhl R, Schmitt-Grohé S, Zielen S, Schubert R.

Cytokine. 2010 May;50(2):152-7. doi: 10.1016/j.cyto.2010.02.004. Epub 2010 Feb 23.

PMID:
20181491
26.

Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.

Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J, Rose MA, Rosewich M, Renz H, Zielen S.

Int Arch Allergy Immunol. 2009;148(3):251-60. doi: 10.1159/000161585. Epub 2008 Oct 10.

PMID:
18849616
27.

Montelukast as add-on therapy to beta-agonists and late airway response.

Rosewich M, Rose MA, Eickmeier O, Travaci M, Kitz R, Zielen S.

Eur Respir J. 2007 Jul;30(1):56-61. Epub 2007 Feb 14.

28.

Effects of long-term treatment with montelukast in mild cystic fibrosis (long term treatment with montelukast in cystic fibrosis).

Schmitt-Grohé S, Eickmeier O, Naujoks C, Schubert R, Lentze MJ, Zielen S, Rietschel E.

Respir Med. 2007 Mar;101(3):684. Epub 2006 Dec 21. No abstract available.

29.

Granular cell tumor of the trachea in a child.

Stieglitz F, Kitz R, Schäfers HJ, Eickmeier O, Rose M, Fellbaum C, Zielen S.

Ann Thorac Surg. 2005 Feb;79(2):e15-6.

PMID:
15680798
30.

Anti-inflammatory effects of montelukast in mild cystic fibrosis.

Schmitt-Grohé S, Eickmeier O, Schubert R, Bez C, Zielen S.

Ann Allergy Asthma Immunol. 2002 Dec;89(6):599-605.

PMID:
12487226

Supplemental Content

Loading ...
Support Center